Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity. | Dis Model Mech | 2023 | 37589075 | PubTator, text mining | PubMed |
| Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects. | J Clin Invest | 2023 | 37581931 | PubTator, text mining | PubMed |
| Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids. | Molecules | 2023 | 37570596 | PubTator, text mining | PubMed |
| Plasma proteomic signatures of enteric permeability among hospitalized and community children in Kenya and Pakistan. | iScience | 2023 | 37554451 | PubTator, text mining | PubMed |
| Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum-infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellular senescence pathway. | Gut Microbes | 2023 | 37550944 | PubTator, text mining | PubMed |
| Interaction mechanisms between autophagy and ferroptosis: Potential role in colorectal cancer. | World J Gastrointest Oncol | 2023 | 37546557 | PubTator, text mining | PubMed |
| Dietary fat differentially modulates the response of bone marrow-derived macrophages to TLR4 and NOD2 agonists. | Innate Immun | 2023 | 37545346 | PubTator, text mining | PubMed |
| Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence. | Asian J Urol | 2023 | 37538166 | PubTator, text mining | PubMed |
| Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. | PLoS One | 2023 | 37535606 | PubTator, text mining | PubMed |
| Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy. | J Neuroinflammation | 2023 | 37533036 | PubTator, text mining | PubMed |
| RIPK2 inhibitors for disease therapy: Current status and perspectives. | Eur J Med Chem | 2023 | 37531744 | PubTator, text mining | PubMed |
| Role of Rab5 early endosomes in regulating Drosophila gut antibacterial response. | iScience | 2023 | 37529104 | PubTator, text mining | PubMed |
| Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution? | Viruses | 2023 | 37515138 | PubTator, text mining | PubMed |
| Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner. | Int J Mol Sci | 2023 | 37511441 | PubTator, text mining | PubMed |
| Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases. | Curr Issues Mol Biol | 2023 | 37504266 | PubTator, text mining | PubMed |
| Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT. | Commun Biol | 2023 | 37491379 | PubTator, text mining | PubMed |
| NOD1 cooperates with HAX-1 to promote cell migration in a RIPK2- and NF-ĸB-independent manner. | FEBS J | 2023 | 37488967 | PubTator, text mining | PubMed |
| Evolution and natural selection of ribosome-inactivating proteins in bacteria, fungi, and plants. | Int J Biol Macromol | 2023 | 37481176 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Novel XIAP mutation with early-onset Crohn's disease complicated with acute heart failure: a case report. | BMC Cardiovasc Disord | 2023 | 37479963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=12